Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
about
Ziconotide: a review of its pharmacology and use in the treatment of painL-arginyl-3,4-spermidine is neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission.Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor.Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays.Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.Alfentanil: correlations between absence of effect upon subcutaneous mast cells and absence of granuloma formation after intrathecal infusion in the dog.Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide.Role of meningeal mast cells in intrathecal morphine-evoked granuloma formation.Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.Pharmacokinetic analysis of ziconotide (SNX-111), an intrathecal N-type calcium channel blocking analgesic, delivered by bolus and infusion in the dog.CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain
P2860
Q24658327-73545FBF-7FA4-4F1A-8D45-83B3909972AEQ30872869-3D4A3041-557D-45D0-8824-56615724E12BQ33390819-97721A09-CA4D-4F3F-95D8-D974D9DADD40Q35042939-006E1C28-4B37-45BB-B2A9-371256ED2BB8Q35693714-56211C65-F55B-427C-927D-2A00C79C3352Q36318896-4865A7FA-FE6D-4D9B-97AA-D89D61F959F8Q36640093-0A84268B-F1DC-4B0C-AEE7-054CEA2B78E6Q36644488-215D5E61-0E27-43B8-B915-F069574B7579Q37210080-1A0C5713-7F0C-4500-BA5B-BC077FA7F8F2Q37427566-41A9C540-2F61-400C-9C58-B7CBBF044105Q39168504-22030671-39D6-4608-896C-E4177558153AQ41914223-40A2C255-91AE-4AEE-8329-937A6A0065F7Q58582878-DB0604CD-D364-49D9-887A-3691BB4145F0
P2860
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
@en
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
@nl
type
label
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
@en
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
@nl
prefLabel
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
@en
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
@nl
P2093
P1476
Cardiovascular effects of omega-conopeptides in conscious rats: mechanisms of action.
@en
P2093
B B Hoffman
K Valentino
S S Bowersox
Z Zukowska-Grojec
P304
P407
P577
1992-01-01T00:00:00Z